Skip to main content
. 2000 Sep 15;20(18):6811–6819. doi: 10.1523/JNEUROSCI.20-18-06811.2000

Fig. 8.

Fig. 8.

Scheme suggesting cascade of events leading to the IL-1β-induced impairment in LTP. Intracerebroventricular injection of IL-1β leads to an increase in reactive oxygen species production that increases activity of JNK and p38. We propose that glutamate release is compromised by activation of IL-1 receptors, one consequence of which is activation of these kinases, and that this inhibition of glutamate release significantly contributes to the IL-1β-induced impairment in LTP.